RecruitingNCT07420946

Mechanical Insufflation-Exsufflation in Critically Ill Patients

Mechanical Insufflation-Exsufflation in Critically Ill Patients: An International DELphi Consensus (DELMI-E)


Sponsor

Medipol University

Enrollment

30 participants

Start Date

Jun 10, 2026

Study Type

OBSERVATIONAL

Conditions

Summary

Mechanical insufflation-exsufflation (MI-E) is an established airway clearance technique for patients with chronic conditions like neuromuscular diseases. However, its use in critically ill ICU patients remains inconsistent and lacks standardized guidelines. Despite growing research, current practices vary widely in patient selection, treatment protocols, and safety management, with limited high-quality evidence to support clear recommendations. To address this gap, an international, multidisciplinary Delphi consensus study is needed to establish expert-based best practices and feasible guidelines for the safe and effective implementation of MI-E in the intensive care setting.


Eligibility

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Delphi Questionnaire for people with airway clearance, consensus, and other related conditions. The study is currently recruiting participants at 4 locations.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERDelphi Questionnaire

Statements on MI-E topics, rated along their level of appropriateness on a scale from 1 to 5. Multiple rounds are organised to reach consensus on a topic.


Locations(4)

Monaldi Hospital A.O.R.N. dei Colli

Naples, Italy

University of Naples Federico II

Naples, Italy

Hospital General Universitario Morales Meseguer

Murcia, Spain

İstanbul Medipol University

Istanbul, Istanbul, Turkey (Türkiye)

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07420946


Related Trials